ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 100 filers reported holding ALBIREO PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,161,000 | +11.6% | 100,000 | 0.0% | 0.46% | +3.1% |
| Q3 2022 | $1,936,000 | -2.5% | 100,000 | 0.0% | 0.45% | -14.7% |
| Q2 2022 | $1,986,000 | -33.4% | 100,000 | 0.0% | 0.53% | -29.6% |
| Q1 2022 | $2,983,000 | +28.1% | 100,000 | 0.0% | 0.75% | +66.2% |
| Q4 2021 | $2,329,000 | -25.4% | 100,000 | 0.0% | 0.45% | -7.8% |
| Q3 2021 | $3,120,000 | -11.3% | 100,000 | 0.0% | 0.49% | +12.9% |
| Q2 2021 | $3,518,000 | -0.2% | 100,000 | 0.0% | 0.43% | -33.2% |
| Q1 2021 | $3,525,000 | -6.0% | 100,000 | 0.0% | 0.65% | +72.4% |
| Q4 2020 | $3,751,000 | +12.4% | 100,000 | 0.0% | 0.38% | -59.5% |
| Q3 2020 | $3,337,000 | – | 100,000 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |